학술논문

Homozygous missense variant in BMPR1A resulting in BMPR signaling disruption and syndromic features
Document Type
article
Source
Molecular Genetics & Genomic Medicine. 7(11)
Subject
Biological Sciences
Genetics
Cardiovascular
Pediatric
Congenital Structural Anomalies
Heart Disease
2.1 Biological and endogenous factors
Aetiology
Abnormalities
Multiple
Adult
Bone Diseases
Developmental
Bone Morphogenetic Protein Receptors
Type I
Cartilage
Craniofacial Abnormalities
Developmental Disabilities
Female
Homozygote
Humans
Infant
Intestinal Polyposis
Male
Muscular Atrophy
Mutation
Missense
Neoplastic Syndromes
Hereditary
Pedigree
Phenotype
Prognosis
atrial septal defect
BMP
bmpr1a protein
bone morphogenetic protein
human
Medicinal and Biomolecular Chemistry
Clinical Sciences
Medicinal and biomolecular chemistry
Language
Abstract
BackgroundThe bone morphogenetic protein (BMP) pathway is known to play an imperative role in bone, cartilage, and cardiac tissue formation. Truncating, heterozygous variants, and deletions of one of the essential receptors in this pathway, Bone Morphogenetic Protein Receptor Type1A (BMPR1A), have been associated with autosomal dominant juvenile polyposis. Heterozygous deletions have also been associated with cardiac and minor skeletal anomalies. Populations with atrioventricular septal defects are enriched for rare missense BMPR1A variants.MethodsWe report on a patient with a homozygous missense variant in BMPR1A causing skeletal abnormalities, growth failure a large atrial septal defect, severe subglottic stenosis, laryngomalacia, facial dysmorphisms, and developmental delays.ResultsFunctional analysis of this variant shows increased chondrocyte death for cells with the mutated receptor, increased phosphorylated R-Smads1/5/8, and loss of Sox9 expression mediated by decreased phosphorylation of p38.ConclusionThis homozygous missense variant in BMPR1A appears to cause a distinct clinical phenotype.